- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Oncology Care Model: Additional Concerns
Bruce Feinberg, DO; Scott Gottlieb, MD; Brian Kiss, MD; and Ted Okon, MBA, continue to discuss the Oncology Care Model established by the CMS and how it is likely to affect physicians and their practices.
Dr Kiss explains why his organization opted not to participate in the Oncology Care Model, but rather to collaborate with healthcare systems independently.
The Oncology Care Model will impact the physician’s choice to see and care for Medicare patients, projects Dr Gottlieb. Additionally, he remarks, the new model is likely to further affect community practices and result in consolidation because of its complex structure and burden on physicians.
Because the model includes a vast number of performance-based measures, and because these measures are constantly changing, physicians don’t understand how they are being measured, explains Mr Okon. To describe the effect of this issue, he compares a physician who attempts to work under the new model with an athlete who tries to play golf blindfolded.
Gefurulimab for gMG Meets Key End Points in PREVAIL Trial
July 28th 2025The primary endpoint in PREVAIL is Myasthenia Gravis-Activities of Daily Living total score improvement from baseline, and the secondary endpoints are Quantitative Myasthenia Gravis total score and Myasthenia Gravis Composite total score.
Read More
